Free Trial

Senti Biosciences (SNTI) SEC Filings & 10K Form

Senti Biosciences logo
$3.28 -0.09 (-2.53%)
As of 01:12 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Senti Biosciences SEC Filings

DateFilerForm TypeView
03/31/2025
11:15 PM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form EFFECT
03/31/2025
11:15 PM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form EFFECT
03/24/2025
5:02 AM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2025
5:12 AM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/21/2025
5:06 AM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/20/2025
3:21 PM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/17/2025
5:35 PM
BAYER HEALTHCARE LLC (Filed by)
Senti Biosciences, Inc. (Subject)
Senti Biosciences (Subject)
Form SCHEDULE 13D
03/17/2025
2:01 PM
Celadon Partners SPV 24 (Filed by)
Senti Biosciences, Inc. (Subject)
Senti Biosciences (Subject)
Form SCHEDULE 13D/A
03/14/2025
10:52 AM
Celadon Partners SPV 24 (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2025
3:32 PM
Celadon Partners SPV 24 (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/12/2025
8:30 PM
BASKETT FOREST (Reporting)
Florence Anthony A. Jr. (Reporting)
Makhzoumi Mohamad (Reporting)
NEA 15 GP, LLC (Reporting)
NEA Partners 15, L.P. (Reporting)
New Enterprise Associates 15, L.P. (Reporting)
SANDELL SCOTT D (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
8:20 PM
BASKETT FOREST (Reporting)
Florence Anthony A. Jr. (Reporting)
Makhzoumi Mohamad (Reporting)
NEA 15 GP, LLC (Reporting)
NEA Partners 15, L.P. (Reporting)
New Enterprise Associates 15, L.P. (Reporting)
SANDELL SCOTT D (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/12/2025
7:31 PM
BAYER AKTIENGESELLSCHAFT (Reporting)
BAYER HEALTHCARE LLC (Reporting)
Bayer US Holding LP (Reporting)
Bayer World Investments B.V. (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
3:17 PM
Hsiung Feng (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
3:20 PM
COOPERSTONE BRENDA (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
3:20 PM
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Tang Donald F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
3:20 PM
Collins James J. (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
3:21 PM
Schulz Fran (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
3:23 PM
Rajangam Kanya (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
6:00 PM
New Enterprise Associates 15, L.P. (Filed by)
Senti Biosciences, Inc. (Subject)
Senti Biosciences (Subject)
Form SCHEDULE 13D/A
03/10/2025
6:01 PM
Lu Timothy K (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
6:02 PM
Rajangam Kanya (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
4:18 PM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2025
4:19 PM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/14/2025
3:31 PM
Nantahala Capital Partners Limited Partnership (Filed by)
Senti Biosciences, Inc. (Subject)
Senti Biosciences (Subject)
Form SCHEDULE 13G
02/06/2025
7:23 PM
Lu Timothy K (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
6:53 PM
Rajangam Kanya (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
4:30 PM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/27/2025
6:30 AM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form DEF 14A
01/15/2025
3:15 PM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form PRE 14A
12/19/2024
3:34 PM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form D
Notice of Exempt Offering of Securities 
12/16/2024
3:09 PM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2024
6:38 PM
BAYER AKTIENGESELLSCHAFT (Reporting)
BAYER HEALTHCARE LLC (Reporting)
Bayer US Holding LP (Reporting)
Bayer World Investments B.V. (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
3:15 PM
Rajangam Kanya (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
3:16 PM
Schulz Fran (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/10/2024
3:17 PM
Schulz Fran (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
3:18 PM
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Tang Donald F (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/10/2024
3:19 PM
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Tang Donald F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2024
3:18 PM
Farokhzad Omid (Reporting)
Senti Biosciences, Inc. (Subject)
Senti Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/02/2024
3:02 PM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/02/2024
7:26 AM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Now I look stupid. Real stupid... (Ad)

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

11/14/2024
3:51 PM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/14/2024
3:32 PM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2024
3:05 PM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2024
3:42 PM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
3:19 PM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/12/2024
3:17 PM
Farokhzad Omid (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2024
3:30 PM
Mathers Edward T (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
3:07 PM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form DEF 14A
05/29/2024
3:09 PM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form DEFA14A
05/17/2024
4:17 PM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/17/2024
4:19 PM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form PRE 14A
05/09/2024
3:19 PM
Li Yvonne (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/09/2024
3:10 PM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2024
3:56 PM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:SNTI) was last updated on 4/1/2025 by MarketBeat.com Staff
From Our Partners